InflaRx NV
NASDAQ:IFRX
InflaRx NV
NASDAQ:IFRX
Price:
0.92
USD
-1.21%
Market Cap:
$61.8m
Balance Sheet
Balance Sheet Decomposition
InflaRx NV
InflaRx NV
Balance Sheet Decomposition is not available for
InflaRx NV
InflaRx NV
Balance Sheet
InflaRx NV
InflaRx NV
Currency: EUR
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
29
|
123
|
22
|
5
|
2
|
14
|
16
|
8
|
4
|
|
| Cash |
0
|
0
|
0
|
22
|
5
|
2
|
14
|
16
|
8
|
4
|
|
| Cash Equivalents |
3
|
29
|
123
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
33
|
110
|
80
|
70
|
66
|
83
|
49
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
7
|
|
| Other Current Assets |
0
|
0
|
1
|
103
|
4
|
4
|
11
|
14
|
4
|
10
|
|
| Total Current Assets |
3
|
29
|
124
|
158
|
119
|
86
|
96
|
97
|
109
|
72
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
27
|
3
|
9
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
30
+723%
|
124
+321%
|
159
+28%
|
122
-24%
|
88
-27%
|
125
+42%
|
102
-18%
|
120
+17%
|
76
-37%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
2
|
4
|
7
|
12
|
2
|
2
|
2
|
6
|
5
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
7
|
7
|
3
|
6
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
10
|
8
|
4
|
2
|
|
| Total Current Liabilities |
0
|
2
|
5
|
8
|
14
|
10
|
19
|
13
|
17
|
14
|
|
| Long-Term Debt |
21
|
53
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
21
N/A
|
55
+160%
|
5
-91%
|
8
+64%
|
14
+84%
|
10
-28%
|
20
+92%
|
14
-29%
|
18
+25%
|
15
-17%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
3
|
3
|
3
|
3
|
5
|
5
|
7
|
7
|
|
| Retained Earnings |
17
|
25
|
117
|
63
|
109
|
142
|
183
|
207
|
246
|
288
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
211
|
211
|
220
|
280
|
283
|
334
|
335
|
|
| Other Equity |
0
|
0
|
0
|
0
|
2
|
4
|
3
|
7
|
7
|
7
|
|
| Total Equity |
18
N/A
|
26
-46%
|
119
N/A
|
151
+27%
|
107
-29%
|
78
-27%
|
105
+35%
|
88
-16%
|
103
+16%
|
61
-40%
|
|
| Total Liabilities & Equity |
4
N/A
|
30
+723%
|
124
+321%
|
159
+28%
|
122
-24%
|
88
-27%
|
125
+42%
|
102
-18%
|
120
+17%
|
76
-37%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
23
|
23
|
24
|
26
|
26
|
28
|
44
|
45
|
59
|
59
|
|
Switch to:
Switch to:
See Also
Discover More
